Seamless Phase IIa/IIb and enhanced dose-finding adaptive design. - Wikidata - awgldk - TriplyDB

Seamless Phase IIa/IIb and enhanced dose-finding adaptive design.

Seamless Phase IIa/IIb and enhanced dose-finding adaptive design.

http://www.wikidata.org/entity/Q37260022

about

PIPELINEs: Creating Comparable Clinical Knowledge Efficiently by Linking Trial Platforms.Seamless phase IIa/IIb adaptive design with the same primary endpoint for proof of concept and dose finding.

P2860

Q37481946-5B0C064B-C3A6-4AD4-AFE0-8F1F637AD64F Q55553948-D32E9EE1-C92D-43F9-954C-F459B0DEA13F

P2860

Seamless Phase IIa/IIb and enhanced dose-finding adaptive design.

http://www.wikidata.org/entity/Q37260022

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 21 September 2015

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Seamless Phase IIa/IIb and enhanced dose-finding adaptive design.

@en

Seamless Phase IIa/IIb and enhanced dose-finding adaptive design.

@nl

type

label

Seamless Phase IIa/IIb and enhanced dose-finding adaptive design.

@en

Seamless Phase IIa/IIb and enhanced dose-finding adaptive design.

@nl

prefLabel

Seamless Phase IIa/IIb and enhanced dose-finding adaptive design.

@en

Seamless Phase IIa/IIb and enhanced dose-finding adaptive design.

@nl

P1433

Q37260022-DF21A5A9-3C94-4362-94D5-A664AD9A13F6

P1476

Q37260022-EDFB46DD-5B0A-4F75-8B71-4677641FACD3

P2093

Q37260022-0D2A00CC-C652-4D7A-ABB5-61C3A5B87980

Q37260022-1FE1B0D6-1C1F-4C48-8A1B-65A6C36359AE

Q37260022-907C5EEB-DAEE-45D0-9E0A-E2408636F2EB

Q37260022-91CCCF18-79C4-444E-AF68-6EC82C211E06

P2860

Q37260022-033B686D-3D13-427E-AB45-91F05FCB3E38

Q37260022-05CBE611-26C1-4379-BB7B-D4B54EC7795F

Q37260022-221E2A19-5F7F-4AB3-A335-B99F902F2144

Q37260022-38B8337D-4939-4C1D-ADC5-53F5C9B18012

Q37260022-6ABE8C74-969C-4CA9-8E74-446D7787934E

Q37260022-6D2B4BA3-1638-4917-BCC3-B25BDD211469

Q37260022-9CFAFBDE-5843-4A1E-9B59-F2EFEF645E2D

Q37260022-BC4B3FBE-F0B0-4C6B-AB03-A0B3666E3D91

Q37260022-C984F456-53A6-4413-B9B5-6093287C1A01

Q37260022-CDFB11D6-6245-447F-899A-0EBA37520574

P304

Q37260022-0E078280-F610-4D20-A950-9678E944EA3E

P31

Q37260022-1BCF16B2-BE10-4579-83FB-A2AB0463D73F

P356

Q37260022-80DB6FF3-4E36-4FA6-9AD5-59541A70F3BF

P433

Q37260022-23C10FAB-D655-416B-A8A0-5DC8F935CF74

P478

Q37260022-E44C6BDC-5528-4A13-A07B-07BBCBCD8A31

P50

Q37260022-3FDD7A0D-F458-440A-BBF4-A8848C285B88

Q37260022-C2971DE0-FFBC-4BE2-9250-E2E5D01DCB81

P577

Q37260022-C932390E-2AD2-49D2-8FE3-A34149757E87

P698

Q37260022-42CB0EBF-3DC8-4621-A839-4144593A667E

P932

Q37260022-98F27EF1-9E5C-42BD-8A76-88EDDB11566C

P356

10543406.2015.1094807

P1433

Journal of Biopharmaceutical Statistics

P1476

Seamless Phase IIa/IIb and enhanced dose-finding adaptive design.

@en

P2093

Dong Xi

http://www.w3.org/2001/XMLSchema#string

Jiacheng Yuan

http://www.w3.org/2001/XMLSchema#string

Peter Mesenbrink

http://www.w3.org/2001/XMLSchema#string

Wenzhao Guo

http://www.w3.org/2001/XMLSchema#string

P2860

Confirmatory seamless phase II/III clinical trials with hypotheses selection at interim: general concepts.

Seamless phase II/III designs.

Seamless phase I-II trial design for assessing toxicity and efficacy for targeted agents.

Graphical approaches for multiple comparison procedures using weighted Bonferroni, Simes, or parametric tests.

A graphical approach to sequentially rejective multiple test procedures.

Dose-finding based on efficacy-toxicity trade-offs.

Test and power considerations for multiple endpoint analyses using sequentially rejective graphical procedures.

A strategy for dose-finding and safety monitoring based on efficacy and adverse outcomes in phase I/II clinical trials.

Simulation as a design tool for phase I/II clinical trials: an example from bone marrow transplantation.

Confirmatory seamless phase II/III clinical trials with hypotheses selection at interim: applications and practical considerations.

P304

912-923

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/10543406.2015.1094807

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-09-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26390951

http://www.w3.org/2001/XMLSchema#string

P932

5025390

http://www.w3.org/2001/XMLSchema#string